I've pointed this out before, but if the Rett's trials are effective, the anecdotal results will likely leak out through social media and the web long before official results (I can't imagine trial recipients would have to sign a NDA).
- Forums
- ASX - By Stock
- NEU
- Ann: Half Yearly Report and Accounts
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.37%
!
$13.16

Ann: Half Yearly Report and Accounts , page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.16 |
Change
0.305(2.37%) |
Mkt cap ! $1.635B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.636M | 353.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 180 | $13.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.16 | 379 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 402 | 13.150 |
6 | 444 | 13.140 |
8 | 697 | 13.130 |
4 | 651 | 13.120 |
8 | 1603 | 13.110 |
Price($) | Vol. | No. |
---|---|---|
13.160 | 581 | 4 |
13.170 | 598 | 7 |
13.180 | 975 | 7 |
13.190 | 1377 | 5 |
13.200 | 2353 | 8 |
Last trade - 12.53pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online